EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU

Size: px
Start display at page:

Download "EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU"

Transcription

1 EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU Gunnar Kahlmeter

2 What is new in EUCAST? New organisms breakpoints 2016 Breakpoints for exisiting agents breakpoints 2016 Temocillin, nitroxoline, Review (and revision) of breakpoints Colistin, fluoroquinolones ongoing consultations carbapenems, aminoglycosides, tigecycline 2016/17 What to do when there are no breakpoints? (SOP 2016) Redefining the intermediate category!? (2017) Instruction videos (commissioned by WHO) ASM Microbe 2016

3 New organisms with breakpoints Kingella kingae Aerococcus spp Aeromonas Plesiomonas Nocardia Bacillus Streptomyces Lactobacillus Leuconostoc ASM Microbe 2016

4 Colistin methods and breakpoints reviewed by joint EUCAST/CLSI subcommittee (Chair John Turnidge, Australia) ASM Microbe 2016

5 Colistin Current and suggested breakpoints Enterobacteriaceae Pseudomonas aeruginosa Acinetobacter Colistin /2 4/4 2/2 Colistin /2 2/2 2/2 ASM Microbe 2016

6 Colistin MIC distributions and ECOFFs ASM Microbe 2016

7 The proposal is to reduce the breakpoint from 4/4 to 2/2 mg/l. ASM Microbe 2016

8 Proposed new ciprofloxacin breakpoints S X / R>Y mg/l ASM Microbe 2016

9 ASM Microbe 2016

10 EUCAST Subcommittee on the role of whole genome sequencing (WGS) in antimicrobial susceptibility testing of bacteria Chair: Neil Woodford, London UK Formed immediately after 2015 ECCMID, Copenhagen 1 st report at ECCMID Report available for consultation until 25 June,

11 Phenotypic vs. Genotypic AST Phenotypic AST WGS-based AST Measures susceptibility Resistance mechanisms (limited) ECOFF (WT vs. non-wt) Clinical resistance (S vs. R) +/- (inferred) Additional data Suitable speed (most) (e.g. TB) (most) (e.g. TB) Cost South Africa 2016

12 Disk diffusion instruction videos EUCAST project 10 videos (5 finalised) financed by WHO. Subtitles in other languages Youtube, WHO webpage, EUCAST webpage. ASM Microbe 2016

13 Uptake of EUCAST guidelines All countries inside Europe have decided to adopt EUCAST guidelines. Increasing numbers of countries outside Europe are going over to EUCAST. Website hits now > per month. User questions from all over the world are increasing. France and the UK have abandoned their respective disk diffusion test. >90% of labs in Queensland, Australia, are now on EUCAST. Almost 90% of NEQAS subscribers are now on EUCAST. All competitors (except CLSI) have resigned and joined EUCAST. ASM Microbe 2016

14 Trends in antimicrobial susceptibility testing guidelines in EARS-Net ASM Microbe 2016

15 ASM Microbe 2016

16 Wide variation in disk quality in 16 disks from nine manufacturers. EUCAST Development Laboratory (EDL) Växjö Sweden

17 Results from First (1) and Second (2) Study Bio-Rad Liofilchem BD Abtek SirScan Oxoid HiMedia Bioanalyse Mast Antimicrobial disk Benzylpenicillin 1 unit L H H NA NA H H Amoxicillin-clav. 30 µg H H* L H H L Piperacillin-tazo. 36 µg L L H NA NA Oxacillin 1 µg L L L H H L Mecillinam 10 µg L H H H Cefotaxime 5 µg 1 NA L NA NA Cefoxitin 30 µg 2 H* H* H H* NA L L* L* L Ceftazidime 10 µg L L L H Meropenem 10 µg 1 H H* L L H H Ciprofloxacin 5 µg 2 L L L L H H* L L Norfloxacin 10 µg L L H* H Pefloxacin 5 µg L L L NA NA NA H Gentamicin 10 µg H L NA H H Tobramycin 10 µg NA NA H H* H* Erythromycin 15 µg L L L L H H L* L Tetracycline 30 µg L L* L* L L* L L L Mean value within ± 1 mm of the target value Mean value >1 mm but within ± 2 mm of the target value Mean value >2 mm from target value but still within the QC range Mean value out of the QC range Disk included in first study, but not supplied for second study NA = Not Available H = High, mean value >1 mm above target L = Low, mean value >1 mm below target * One or more readings out of QC range 1 Data has been reanalyzed due to changes in QC criteria for H. influenzae ATCC with cefotaxime 5 µg (2015) and E. coli ATCC with meropenem 10 µg (2016). 2 For specific comments on cefoxitin and ciprofloxacin, see next slide. 17

18 ASM Microbe 2016

19 EUCAST has agreed to evaluate follow up disk lots on the request of manufacturers. We have invited manufacturers with disk problems to review production procedures and QC and to send us new lots for testing. Several manufacturers availed themselves of this offer. Here is one example: Previous results Results Antimicrobial disk Manufacturer New disk lot New disk lot tested 1 2 new lot Meropenem 10 µg Bio-Rad H 5K00E2 May 2016 Mean value within ± 1 mm of the target value Mean value >1 mm but within ± 2 mm of the target value Mean value >2 mm from target value but still within the QC range Mean value out of the QC range Disk included in first study, but not supplied for second study NA = Not Available H = High, mean value >1 mm above target L = Low, mean value >1 mm below target * One or more readings out of QC range 19

20 Warnings on EUCAST website South Africa May 2016

21 What to do when there are no breakpoints in the EUCAST table? Gunnar Kahlmeter

22 AST - when there is no breakpoint? EUCAST SOP The breakpoint is IE 2. The breakpoint is 3. The agent is not in the table 4. The species is not in the table 5. The MIC breakpoints lack zone diameter correlates South Africa 2016

23 1. Breakpoint table indicates IE IE : insufficient evidence EUCAST has evaluated the agent/species There is not enough evidence to support a clinical breakpoint in vitro data encouraging. South Africa 2016

24 2. Breakpoint table indicates - - : intrinsic resistance EUCAST has evaluated the agent/species available evidence suggests that the agent is clinically ineffective irrespective of dose. In vitro data not encouraging. South Africa 2016

25 3. The agent is not in the table Agent available only in few countries The juice is not worth the queeze (streptomycin, josamycin, spiramycin, sparfloxacin) New agent waiting for breakpoints as part of registration (EMA, FDA) process, breakpoints in semi-automated systems (biomerieux, BD, Siemens etc) waiting to be developed or approved. zone diameter correlates to MIC breakpoints (EUCAST, CLSI) waiting to be developed. Reliable AST difficult or not possible - fosfomycin (agar dilution only), caspofungin

26 4. The species is not in the table 1. Species/subspecies considered poor target for agent E. coli and vancomycin, Enterococci and cephalosporins, 2. Species/Subspecies considered of doubtful/low clinical importance Bacillus spp., Campylobacter laridis, Yersinia fredericksoniae 3. Rare species Erysopelothrix rusopathiae, Kingella kingae, Aerococcus spp 4. Common species but rare subspecies in human medicine Haemophilus aphrophilus 5. Clinical outcome data insufficient or not available Campylobacter laridis vs. erythromycin 6. Reliable MIC determination not possible Acinetobacter vs. cephalosporins, Stenotrophomonas vs. moxifloxacin m fl, Burkholderia spp.

27 There is no solution unless a reproducible MIC can be determined

28 Sometimes there are species and agents not mentioned in EUCAST tables but present in CLSI tables. CLSI needs to decide whether or not they take responsibility for these. Example: Chloramphenicol breakpoints for Enterococci. South Africa 2016

29 Where there is no breakpoint Is there a breakpoint for a related organism? Is there a PK/PD breakpoint to guide? Is there an MIC wild type distribution for the species and agent? If so, determine if the isolate is wild type (devoid of resistance mechanisms) or non-wild type (with resistance mechanisms)

30 Breakpoints for related organisms Find breakpoints for related organisms and interpret accordingly. Campylobacter laridis, use C.jejuni and C.coli; Haemophilus aphrophilus, use Haemophilus influenzae, Enterococcus bovis, use Enterococcus faecium, etc Proceed with caution

31 Isolates where there is no breakpoint Is there a breakpoint for a related organism? Is there a PK/PD breakpoint to guide? Is there an MIC wild type distribution for the species and agent? If so, determine if the isolate is wild type (devoid of resistance mechanisms) or non-wild type (with resistance mechanisms)

32 Exempel: Leuconostoc spp. benzylpenicillin MIC 0.25 mg/l PK/PD (Non-species related) breakpoints EUCAST Clinical Breakpoint Table v. 6.0, valid from These breakpoints are used only when there are no species-specific breakpoints or other recommendations (a dash or a note) in the speciesspecific tables. Penicillins MIC breakpoint Notes (mg/l) S R > Benzylpenicillin For susceptibility testing purposes, the concentration of sulbactam is fixed at 4 mg/l. Ampicillin For susceptibility testing purposes, the concentration of clavulanic acid is fixed at 2 mg/l. 3. For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/l. Ampicillin-sulbactam Amoxicillin 2 8 Amoxicillin-clavulanic acid Piperacillin 4 16 Piperacillin-tazobactam Ticarcillin 8 16 Ticarcillin-clavulanic acid Phenoxymethylpenicillin IE IE Oxacillin IE IE Cloxacillin IE IE Dicloxacillin IE IE Flucloxacillin IE IE Mecillinam IE IE

33 EUCAST PK-PD breakpoints Last tab in the breakpoint table PK/PD (Non-species related) breakpoints EUCAST Clinical Breakpoint Table v. 6.0, valid from These breakpoints are used only when there are no species-specific breakpoints or other recommendations (a dash or a note) in the species-specific tables. Penicillins Penicillin MIC breakpoint (mg/l) S R > Notes Benzylpenicillin For susceptibility testing purposes, the concentration of sulbactam is fixed at 4 mg/l. Ampicillin For susceptibility testing purposes, the concentration of clavulanic acid is fixed at 2 mg/l. 3. For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/l. Ampicillin-sulbactam Amoxicillin 2 8 Amoxicillin-clavulanic acid Piperacillin 4 16 Piperacillin-tazobactam Ticarcillin 8 16 Ticarcillin-clavulanic acid Phenoxymethylpenicillin IE IE Oxacillin IE IE Cloxacillin IE IE Dicloxacillin IE IE Flucloxacillin IE IE Mecillinam IE IE MIC breakpoint (mg/l) S R> Benzylpenicillin Ampicillin 2 8 Ampicillin-sulbactam Amoxicillin 2 8 Amoxicillin-clavulanic acid Piperacillin 4 16 Piperacillin-tazobactam Ticarcillin 8 16 Ticarcillin-clavulanic acid

34 Isolates where there is no breakpoint Is there a breakpoint for a related organism? Is there a PK/PD breakpoint to guide? Is there an MIC wild type distribution for the species and agent? If so, determine if the isolate is wild type (devoid of resistance mechanisms) or non-wild type (with resistance mechanisms)

35

36

37

38 Check MIC against the wild type distribution for the species (or a closely related species) If an MIC distribution is available check whether the organism is wild type e.g. Lactobacillus spp., Erythromycin MIC 0.5 mg/l

39 How to report?

40 1. Breakpoint table IE IE : insufficient evidence Compare the MIC with wild type distributions and the PK/PD breakpoint. Report the MIC (not essential) and a comment South Africa 2016

41 2. Breakpoint table - - : intrinsic resistance If a report is warranted, report resistant without testing. South Africa 2016

42 3. Agent not in table Can a surrogate agent be used for testing and categorisation? Erythromycin for macrolide (josamycin) Ciprofloxacin for gramnegatives vs. fluoroquinolone; Norfloxacin for grampositives and a fluroquinolone. Vancomycin for a glycopeptide. Colistin for polymyxin?

43 4. Species not in table Check MIC against breakpoints of a related species. Report the result of the comparison. Check MIC against PK/PD breakpoints. Report as below or above the PK/PD breakpoints. Check MIC against the wild type MIC distribution of the species or a related species Report as without or with resistance mechanisms. Report MIC (not essential) + comment

44 When there are no breakpoints Do not report S, I or R These are susceptibility categories based on evidence for or against favorable clinical outcome. Add a comment instead. South Africa 2016

45 Thank you! This advice will be developed into an SOP on the EUCAST Website.

46 Alla rekommendationer bygger på att ett MIC-värde kan bestämmas. Om ett MIC-värde kan bestämmas med någon säkerhet, kan en bedömning göras mot EUCASTs PK/PD-brytpunkter (se brytpunktstabell eller rational dokument), brytpunkter för närbesläktad art mot MIC-databasen (WT/NWT) för aktuell eller närbesläktad art.

47 Jämför isolatets MIC-värde med MIC-fördelningen för arten eller en närbesläktad art. e.g. Arcanobacterium haemolyticum with vancomycin MIC 0.5 mg/l Gram-positive bakteriers vancomycin vildtyp är vanligen mg/l

48 Bedömning Om det aktuella isolatets MIC-värde är >PK/PD S-brytpunkten >EUCAST-brytpunkten för en närbesläktad art >ECOFF för arten eller en närbesläktad art besvara med R (aldrig I).

49 Bedömning Om det aktuella isolatets MIC-värde är PK/PD S-brytpunkten EUCAST-brytpunkten för en närbesläktad art ECOFF för arten eller en närbesläktad art besvara med en kommentar: Det saknas brytpunkter varför resistensbestämning ej kan utföras. Med utgångspunkt från de undersökningar vi kunnat utföra bedömer vi att isolatet kan behandlas med antibiotikum X.

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne

Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne Antimicrobial susceptibility testing challenges Linda Joyce St Vincent s Hospital Melbourne Bacteria/antimicrobials without breakpoints (B.A.W.B.S.) Enterobacteriacae Pseudomonas aeruginosa, Acinetobacter

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

Main objectives of the EURL EQAS s

Main objectives of the EURL EQAS s EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)

More information

IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE

IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE Robert P. Rennie Professor Emeritus Laboratory Medicine and Pathology University

More information

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

RCH antibiotic susceptibility data

RCH antibiotic susceptibility data RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological

More information

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Penicillins - EUCAST clinical MIC breakpoints (version 1.3) EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

BSAC antimicrobial susceptibility

BSAC antimicrobial susceptibility BSAC antimicrobial susceptibility testing - from Stokes to European harmonization to world? Derek Brown 23 March 2011 BSAC antimicrobial susceptibility testing ti pre-working Party BSAC meetings from the

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21 www.wslhpt.org 2601 Agriculture Drive Madison, WI 53718 (800) 462-5261 (608) 265-1111 2015-BactiR Reg3 Shipment Date: September 14, 2015 Questions or comments should be directed to Amanda Weiss at 800-462-5261

More information

AMR Industry Alliance Antibiotic Discharge Targets

AMR Industry Alliance Antibiotic Discharge Targets AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate

More information

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author EUCAST and susceptibility testing Europe and beyond Gunnar Kahlmeter EUCAST, ESCMID Antimicrobial susceptibility testing To guide therapy and predict clinical outcome in individual patients (clinical breakpoints)

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ... SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods Susceptibility testing of infrequently isolated fastidious organisms Luis Martinez-Martínez Service of Microbiology

More information

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) A report to ISC presented by Paul M. Tulkens representative of

More information

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Antimicrobial susceptibility of Salmonella, 2016

Antimicrobial susceptibility of Salmonella, 2016 susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

Practical approach to Antimicrobial susceptibility testing (AST) and quality control Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,

More information

EUCAST 2010 Why European breakpoints?

EUCAST 2010 Why European breakpoints? EUCAST 2010 Why European breakpoints? Gunnar Kahlmeter Chairman of EUCAST Clinical microbiology Växjö, Sweden gunnar.kahlmeter@ltkronoberg.se Antimicrobial susceptibility testing to predict success and

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...

More information

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

Available online at ISSN No:

Available online at  ISSN No: Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association

More information

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014 vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical

More information

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

EUCAST expert rules in antimicrobial susceptibility testing

EUCAST expert rules in antimicrobial susceptibility testing REVIEW BACTERIOLOGY EUCAST expert rules in antimicrobial susceptibility testing R. Leclercq 1,2, R. Cantón 2,3,4, D. F. J. Brown 4, C. G. Giske 2,4,5, P. Heisig 2,6, A. P. MacGowan 4,7, J. W. Mouton 4,8,

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb. Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the

More information

The Very Latest from the CLSI AST Subcommittee.

The Very Latest from the CLSI AST Subcommittee. 2 0 1 4 The Very Latest from the CLSI AST Subcommittee. Susan E. Sharp, Ph.D., DABMM, FAAM Director - Regional Laboratory Director - Regional Microbiology/Molecular Infectious Diseases Diagnostics Laboratory

More information

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Dr Pat Mitchell R & I Manager Production Stewardship APL CDC Conference, Melbourne June 2017 Dr Kylie Hewson

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Campylobacter Workshop The 7th -8th of Oct. 2008 National Veterinary Institute Uppsala, Sweden Legislation The Commission has

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR

More information

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and some personal thinking Paul M. Tulkens Representative of

More information

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP) Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

STAPHYLOCOCCI: KEY AST CHALLENGES

STAPHYLOCOCCI: KEY AST CHALLENGES Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu STAPHYLOCOCCI: KEY AST CHALLENGES THE CHALLENGES detection of penicillin resistance detection

More information

Monthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone):

Monthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone): Monthly Webinar Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm Event number: 849 291 546 Audio dial-in (phone): 01 526 0058 AMS InSight Monthly Webinar: Tuesday 12th December MicroB: Brewing

More information

BSAC standardized disc susceptibility testing method (version 8)

BSAC standardized disc susceptibility testing method (version 8) Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Trends en voorkomen van resistenties bij Salmonella, Campylobacter en E. coli geïsoleerd uit de voeding

Trends en voorkomen van resistenties bij Salmonella, Campylobacter en E. coli geïsoleerd uit de voeding Trends en voorkomen van resistenties bij Salmonella, Campylobacter en E. coli geïsoleerd uit de voeding Cristina Garcia-Graells, Nadine Botteldoorn, Katelijne Dierick NRL AMR Food Pathogens - AMCRA 30/06/2017

More information

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of

More information

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis

More information

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance

More information

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013 Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial

More information

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011

More information

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance

More information

Antimicrobials. Antimicrobials

Antimicrobials. Antimicrobials Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital 2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....

More information